STOCK TITAN

Privia Health reports $374M in 2025 Medicare shared savings

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Privia Health Group, Inc. (PRVA) reported $374.0 million in 2025 MSSP shared savings, up 59.7% from 2024, shared among CMS, its ACOs and participating provider partners. Excluding an ACO acquired in December 2025, shared-savings growth was 38.1%. Ten ACOs managed more than $4.0 billion in benchmark spend, serving more than 297,000 Medicare beneficiaries through over 4,700 providers. Per-beneficiary expenditures were 8% below the median MSSP ACO and 22% below Medicare.

Privia raised 2026 Adjusted EBITDA guidance to $174–177 million from $154–157 million, and GAAP revenue guidance to $2.55–2.60 billion from $2.50–2.55 billion. Care Margin guidance rose to $565–570 million from $535–540 million; Platform Contribution to $305–310 million from $280–285 million. Management expects at least $550 million in year-end cash, including the American Choice Healthcare transaction capital outlay and assuming the 2025 MSSP cash settlement and related provider disbursements occur before year-end based on current accruals. Guidance for Implemented Providers and Attributed Lives is unchanged.

1 point · 1 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Major point. Forward-looking: it has not happened yet and may not happen.2026 Adjusted EBITDA guidance rose to $174–177 million from $154–157 million.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
MSSP shared savings $374.0 million Achieved by Privia’s ten ACOs for the 2025 performance year; shared among CMS, Privia ACOs and participating provider partners
Year-over-year shared-savings change 59.7% increase 2025 performance year compared with 2024
Adjusted EBITDA guidance $174–177 million Updated full-year 2026 guidance; previous guidance was $154–157 million
GAAP Revenue guidance $2.55–2.60 billion Updated full-year 2026 guidance; previous guidance was $2.50–2.55 billion
Care Margin guidance $565–570 million Updated full-year 2026 guidance; previous guidance was $535–540 million
Platform Contribution guidance $305–310 million Updated full-year 2026 guidance; previous guidance was $280–285 million
Year-end cash and cash equivalents At least $550 million Management expectation for year-end 2026, subject to the stated MSSP settlement and provider-disbursement assumption
Aggregate savings rate 9.3% Across ten ACOs; 11.2% excluding the ACO acquired in December 2025
Medicare Shared Savings Program regulatory
"through the Medicare Shared Savings Program (MSSP)"
A Medicare Shared Savings Program (MSSP) is a government program that lets groups of doctors, hospitals or other healthcare providers team up to manage a patient population’s care and share any Medicare savings they generate while meeting quality targets. For investors, it matters because participation can change a provider’s revenue mix, create incentives to reduce costs and improve outcomes, and therefore affect profitability and risk much like a bonus plan that rewards both efficiency and quality.
Accountable Care Organizations medical
"its Accountable Care Organizations (ACOs) achieved shared savings"
Accountable care organizations are groups of doctors, hospitals and other health providers that agree to coordinate patient care and share financial responsibility for costs and quality. Think of them as a team that gets a single budget for a patient’s care and is rewarded for keeping people healthy and spending less; for investors, ACOs change how providers earn revenue, shift financial risk, and can influence future margins and payer contracts.
Attributed Lives financial
"guidance for Implemented Providers and Attributed Lives both unchanged"
Attributed lives are the number of patients or plan members officially assigned to a health-care provider, insurer, or program for the purpose of measuring care, costs, or payments. Think of it as a roster of customers a company is responsible for; the size and health of that roster determine revenue potential, per-person costs, and financial risk, so changes in attributed lives can materially affect a health-related business’s earnings and valuation.
gross per capita savings financial
"gross per capita savings of $1,258"
Adjusted EBITDA financial
"guidance for Adjusted EBITDA"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Care Margin financial
"guidance for Care Margin"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much MSSP shared savings did PRVA’s ACOs generate in 2025?

Privia’s ten ACOs generated $374.0 million in shared savings for the 2025 performance year, up 59.7% from 2024. The savings are shared among CMS, Privia ACOs and participating provider partners; excluding the ACO acquired in December 2025, year-over-year growth was 38.1%.

What 2026 financial guidance did PRVA raise?

Privia raised Adjusted EBITDA guidance to $174–177 million and GAAP revenue guidance to $2.55–2.60 billion. Care Margin guidance is $565–570 million, Platform Contribution is $305–310 million, and Practice Collections are $3.95–4.00 billion for full-year 2026.

How did PRVA’s ACO utilization metrics compare with benchmarks?

Primary-care visits per 1,000 beneficiaries were 26% and 27% higher than the median MSSP ACO and national fee-for-service Medicare, respectively. Inpatient discharges per 1,000 were 19% and 30% lower, while emergency department visits per 1,000 were 17% and 26% lower, compared with those benchmarks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001759655FALSE00017596552026-11-182026-11-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
FORM 8-K
_______________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 18, 2026
_________________________
Privia Health Group, Inc.
(Exact Name of Registrant as Specified in Its Charter)
_________________________
Delaware
001-4036581-3599420
(State or other jurisdiction of incorporation or organization)
(Commission
File No.)
(I.R.S. Employer Identification No.)
950 N. Glebe Rd.,
Suite 700
Arlington,Virginia22203
(Address of Principal Executive Offices)
(Zip Code)
(571) 366-8850
Registrant's telephone number, including area code

Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par value per sharePRVAThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 7.01. Regulation FD Disclosure
On November 18, 2026, Privia Health Group, Inc. (the “Company”) issued a press release announcing its 2025 performance results in the Medicare Shared Savings Program and updating guidance for full-year 2026. A copy of the press release is attached hereto as Exhibit 99.1.
The materials are attached as Exhibit 99.1 to this Current Report on Form 8-K, are incorporated into this Item 7.01 by reference and are available on our investor relations website at ir.priviahealth.com. This information may be amended or updated at any time and from time to time through another Current Report on Form 8-K, a later company filing, or other means.
The information in this Current Report on Form 8-K (including the exhibit) is furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in the Report that is required to be disclosed solely by Regulation FD.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibit:
Exhibit No.Description
99.1
Privia Health Group, Inc. Press Release Dated November 18, 2026
104Cover Page Interactive Data File (formatted as Inline XBRL)



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PRIVIA HEALTH GROUP, INC.
Date: November 18, 2026
By:/s/ David Mountcastle
Name: David Mountcastle
Title: Executive Vice President, Chief Financial Officer and Authorized Officer

privialogoa.jpg
Exhibit 99.1
Privia Health Reports Strong Results in the 2025 Performance Year
of the Medicare Shared Savings Program
Privia Health’s Ten ACOs Delivered $374 Million in Total Medicare Savings
Company Increases Full-Year 2026 Financial Guidance
a
ARLINGTON, Va., November 18, 2026 — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of $374.0 million through the Medicare Shared Savings Program (MSSP) for the 2025 performance year, a 59.7% increase from 2024. Total year-over-year shared savings growth was 38.1%, excluding the Evolent Care Partners’ ACO acquired in December 2025. The achieved savings noted above are shared between the Centers for Medicare & Medicaid Services (CMS), the Privia ACOs and its participating provider partners.
The ten ACOs (collectively, Privia Quality Network or PQN) managed over $4.0 billion in healthcare benchmark spend through more than 4,700 providers delivering high-value, cost-efficient care to more than 297,000 Medicare beneficiaries in 2025.
“Our strong performance in the 2025 Medicare Shared Savings Program underscores the effectiveness of our physician-led approach and the value of our comprehensive partnerships with physicians across multiple payer arrangements,” stated Dr. Bartley Bryt, Chief Medical Officer. “By putting physicians in the driver's seat and equipping them with essential tools, talent, and technology, we help improve outcomes for over 297,000 Medicare beneficiaries while managing the total cost of care.
“Our approach extends beyond MSSP, supporting physician practices across their entire patient populations and payer arrangements,” Dr. Bryt further elaborated, “By empowering physicians with data-driven insights, operational support, and aligned incentives, we help advance the quadruple aim: better patient outcomes, improved patient experiences, lower healthcare costs, and a better experience for the clinicians delivering care in our communities.”
Privia achieved strong performance across all of its network of physician-led ACOs. This points to the effectiveness of Privia’s primary care-centric partnership model and deep clinician-patient relationships that delivered significant, measurable clinical improvements and utilization outcomes during the MSSP 2025 performance year. Key performance metrics included:

•Higher Primary Care Visits in Lower Cost Setting: Primary care visits per 1,000 beneficiaries were 26% higher than the median MSSP ACO and 27% higher than national fee-for-service Medicare, highlighting Privia’s primary care-centric model providing access to patients in a lower cost setting that helps mitigate the need for higher cost care
•Lowered Acute Hospitalizations: Inpatient hospital discharges per 1,000 beneficiaries were 19% lower than the median MSSP ACO and 30% lower than national Medicare
•Reduced Emergency Care: Emergency department visits per 1,000 beneficiaries were 17% lower than the median MSSP ACO and 26% lower than national Medicare
•Preventing High-Cost Hospital Events: The favorable differences in facility care rates between Privia ACOs and Medicare suggest Privia reduced unnecessary inpatient stays by more than 18,000 and emergency department visits by over 13,000
•Significant Savings: Beneficiary per capita expenditures were 8% lower than the median MSSP ACO and 22% lower than Medicare
•Increased Savings Rate: Privia generated an aggregate savings rate of 9.3% across its ten ACOs. Excluding the ACO acquisition noted above, Privia’s ACOs delivered an aggregate savings rate of 11.2%, an increase of more than 20% over performance year 2024


privialogoa.jpg
Exhibit 99.1
•Significantly Higher Gross Per Capita Savings: In aggregate, Privia’s ten ACOs significantly outperformed all ACOs with higher gross per capita savings. Privia’s ACOs delivered gross per capita savings of $1,258, more than 82% better when compared with all ACOs’ gross per capita savings of $690, according to CMS
Privia Quality Network supports physician practices and more than 1.67 million attributed lives in CMS Medicare programs, Medicare Advantage, Commercial, and Medicaid arrangements. Since 2014, PQN has delivered total shared savings of over $1.9 billion across these programs, including approximately $1.3 billion through participation in the MSSP.
Financial Guidance Update a
Based on Privia's 2025 MSSP results, management increased its financial guidance for full-year 2026, with its guidance for Implemented Providers and Attributed Lives both unchanged. Updated full-year 2026 financial guidance is as follows:
Updated GuidanceGuidance at 11.5.26
($ in millions)
GAAP Revenue  $ 2,550 - 2,600  $ 2,500 - 2,550
Practice Collections  $ 3,950 - 4,000  $ 3,900 - 3,950
Care Margin  $ 565 - 570$ 535 - 540
Platform Contribution  $ 305 - 310 $ 280 - 285
Adjusted EBITDA  $ 174 - 177$ 154 - 157
EBITDA Margin (at midpoint)
(as a % of Care Margin)
30.9 %28.9%
(a) Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures of gross margin, operating income and net income. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons, management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures.

Privia’s updated 2026 guidance reflects Adjusted EBITDA growth of approximately 39.8% at the midpoint as compared to 2025. Privia Health now expects to end this year with at least $550 million in cash and cash equivalents, including the capital outlay for the American Choice Healthcare transaction and assuming the 2025 MSSP cash settlement and related provider disbursements occur before year end based on current accruals. The Company expects to report its fourth quarter and full-year 2026 financial and operating results in late February 2027. Shared savings achieved in MSSP for the 2025 performance year may not be indicative of results in future performance years.

About Privia Health
Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 25 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize ~1,400 physician practices, improve the patient experience for 6.3+ million patients, and reward 5,800+ physicians and advanced practitioners for delivering high-value care.
Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com.


privialogoa.jpg
Exhibit 99.1
Safe Harbor Statement
Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “aims,” “anticipates,” "assumes," “believes,” “estimates,” “expects,” “forecasts,” “future,” “intends,” “likely,” “may,” “outlook,” “plans,” “potential,” “projects,” “seeks,” “strategy,” “targets,” “trends,” “will,” “would,” “could,” “should,” and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things: our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full-year guidance for 2026. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements. Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures of gross margin, operating income and net income. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons, management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures.
Factors related to these risks and uncertainties include, but are not limited to: the heavily regulated industry in which we operate, and any failure by us or our medical groups to comply with the extensive applicable healthcare laws and government regulations; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia providers, and the impact of legal challenges or shifting interpretations of applicable laws; the execution of our growth strategy, which may not prove viable and we may not realize expected results; difficulties timely implementing our proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in our industry; challenges in successfully establishing a presence in new geographic markets; the impact of failures by or service disruptions at key third-party vendors, such as our primary electronic medical record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by governmental and third-party payers, changes to payment terms or challenges negotiating and retaining favorable contracts with private third-party payers, and changes impacting our patient population; the financial and operational impact of our compliance with various complex and changing federal and state privacy and security laws and regulations related to our use, disclosure, and other processing of personal information and protected health information, including the Health Insurance Portability and Accountability Act of 1996; the impact of actual and potential security threats, cybersecurity incidents or privacy or other forms of data breaches involving us, our vendors or other third parties; the continued availability of qualified workforce, including staff at our medical groups, and the continued upward pressure on compensation for such workforce; and other risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2025 and the Company’s subsequent Quarterly Reports on Form 10-Q. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.



privialogoa.jpg
Exhibit 99.1
Contact:
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com     
priviapress@priviahealth.com
817.783.4841

Filing Exhibits & Attachments

4 documents

Keep reading